Linked Data API

Show Search Form

Search Results

1582447
star this property registered interest false more like this
star this property date less than 2023-01-31more like thismore than 2023-01-31
star this property answering body
Department for Business, Energy and Industrial Strategy remove filter
star this property answering dept id 201 more like this
star this property answering dept short name Business, Energy and Industrial Strategy more like this
star this property answering dept sort name Business, Energy and Industrial Strategy more like this
star this property hansard heading Drugs: Manufacturing Industries remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what support he is providing to businesses in the pharmaceutical sector to (a) expand their premises and (b) manufacture more products. more like this
star this property tabling member constituency Witham more like this
unstar this property tabling member printed
Priti Patel more like this
star this property uin 136593 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-02-07more like thismore than 2023-02-07
star this property answer text <p>In 2021, the Government published the Life Sciences Vision, which set out an ambition to create a globally competitive environment for Life Science manufacturing investments. To help meet these ambitions and incentivise globally mobile manufacturing investments in the UK, the Office for Life Sciences launched the £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) in March 2022. The LSIMF will provide capital grants for investment in the manufacture of human medicines (drug substance and drug product), medical diagnostics and medical technology products. The fund has received a large number of high-quality applications and we expect to announce the successful grant awards from spring 2023.</p> more like this
star this property answering member constituency Wealden more like this
star this property answering member printed Ms Nusrat Ghani more like this
star this property question first answered
less than 2023-02-07T15:38:59.2Zmore like thismore than 2023-02-07T15:38:59.2Z
star this property answering member
4460
star this property label Biography information for Ms Nusrat Ghani more like this
star this property tabling member
4066
star this property label Biography information for Priti Patel more like this
1198447
star this property registered interest false more like this
star this property date less than 2020-06-01more like thismore than 2020-06-01
star this property answering body
Department for Business, Energy and Industrial Strategy remove filter
star this property answering dept id 201 more like this
star this property answering dept short name Business, Energy and Industrial Strategy more like this
star this property answering dept sort name Business, Energy and Industrial Strategy more like this
star this property hansard heading Drugs: Manufacturing Industries remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to support domestic pharmaceutical manufacturing capacity during the covid-19 outbreak. more like this
star this property tabling member constituency High Peak more like this
unstar this property tabling member printed
Robert Largan more like this
star this property uin 52620 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2020-06-09more like thismore than 2020-06-09
star this property answer text <p>The Government continues to strongly support the vision set out in the Life Sciences Industrial Strategy to make the UK a top tier global hub for biomedical and clinical research, and medical innovation.</p><p> </p><p>We recognise the importance of life sciences and medicines supply during this pandemic and the Governments recognition of this group as being key workers has ensured pharmaceutical manufacturing has continued throughout the outbreak. The Government is determined to protect lives and protect livelihoods.</p><p> </p><p>Vaccine and therapeutics for Covid-19 are moving rapidly through clinical trials. Government is working closely with industry to assess UK manufacturing capability for a range of potential new vaccines. The type of capacity and the specific groups needed to take this further will be determined by the technology used to produce the vaccines and the type of vaccine produced.</p><p> </p><p>We have also announced a further £93 million to accelerate the building of the new Vaccines Manufacturing and Innovation Centre so it can open in summer 2021, a year ahead of schedule.</p><p> </p><p>While the centre is being built, the Government will establish a rapid deployment facility thanks to a further investment of £38m to begin manufacturing at scale from this summer.</p>
star this property answering member constituency Derby North more like this
star this property answering member printed Amanda Solloway more like this
star this property question first answered
less than 2020-06-09T13:29:14.893Zmore like thismore than 2020-06-09T13:29:14.893Z
star this property answering member
4372
star this property label Biography information for Amanda Solloway more like this
star this property tabling member
4852
star this property label Biography information for Robert Largan more like this